David Shaw’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

David Shaw’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,909	Closed	-$266K	–	3956
2017 Q4	$266K	Sell	10,909 -2,288	-17%	-$44K	﹤0.01%	3293
2017 Q3	$244K	Buy	+13,197	New	+$229K	﹤0.01%	3222
2016 Q3	–	Sell	-27,226	Closed	-$497K	–	3675
2016 Q2	$497K	Buy	27,226 +108	+0.4%	+$1.86K	﹤0.01%	2804
2016 Q1	$493K	Buy	27,118 +9,947	+58%	+$161K	﹤0.01%	2796
2015 Q4	$290K	Buy	+17,171	New	+$292K	﹤0.01%	3379
2015 Q3	–	Sell	-17,400	Closed	-$450K	–	4036
2015 Q2	$450K	Sell	17,400 -17,722	-50%	-$448K	﹤0.01%	3219
2015 Q1	$769K	Buy	+35,122	New	+$758K	﹤0.01%	2752

David Shaw's ENTL Position: Q1 2018 in Review

David Shaw sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 10,909 shares — an estimated $266K sold.

David Shaw first reported a position in ENTL in Q1 2015 and held it in 7 quarters. The position peaked at $769K in Q1 2015. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

David Shaw reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
David Shaw sold 10,909 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $266K.
David Shaw first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
David Shaw's Entellus Medical, Inc. Common Stock position peaked at $769K in Q1 2015.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.